First-in-Class Dual Hybrid Carbonic Anhydrase Inhibitors and Transient Receptor Potential Vanilloid 1 Agonists Revert Oxaliplatin-Induced Neuropathy-Reference-Cited by-同舟云学术

First-in-Class Dual Hybrid Carbonic Anhydrase Inhibitors and Transient Receptor Potential Vanilloid 1 Agonists Revert Oxaliplatin-Induced Neuropathy

Published:2023-01-10 Issue:2 Volume:66 Page:1616-1633
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Angeli Andrea¹^ORCID,Micheli Laura²,Carta Fabrizio¹^ORCID,Ferraroni Marta³^ORCID,Pirali Tracey⁴^ORCID,Fernandez Carvajal Asia⁵,Ferrer Montiel Antonio⁵,Di Cesare Mannelli Lorenzo²,Ghelardini Carla²,Supuran Claudiu T.¹^ORCID

Affiliation:

1. NEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy

2. Pharmacology and Toxicology Section, Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, viale Gaetano Pieraccini 6, 50139 Firenze, Florence, Italy

3. Department of Chemistry ″Ugo Schiff″, University of Florence, via della Lastruccia 3-13, I-50019 Sesto Fiorentino, Italy

4. Dipartimento Di Scienze del Farmaco, Università Degli Studi del Piemonte Orientale, 28100 Novara, Italy

5. Instituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE), Universitas Miguel Hernández, 03202 Elche, Spain

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c01911

Reference48 articles.

1. Cancer Statistics, 2021

2. Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival